Nukkleus Inc. Files 8-K: Material Agreement & Other Events
Ticker: DFNSW · Form: 8-K · Filed: Aug 25, 2025 · CIK: 1787518
Sentiment: neutral
Topics: material-agreement, corporate-event
Related Tickers: NUKK
TL;DR
Nukkleus Inc. signed a big deal on Aug 20, 2025. 8-K filed.
AI Summary
Nukkleus Inc. entered into a material definitive agreement on August 20, 2025. The filing also includes other events and financial statements and exhibits. The company, formerly known as Brilliant Acquisition Corp, is incorporated in Delaware and its fiscal year ends on September 30.
Why It Matters
This 8-K filing signals a significant development for Nukkleus Inc., likely involving a new contract or partnership that could impact its future operations and financial performance.
Risk Assessment
Risk Level: medium — Material definitive agreements can introduce new risks or opportunities, and the lack of specific details in this initial filing warrants a medium risk assessment.
Key Players & Entities
- Nukkleus Inc. (company) — Registrant
- Brilliant Acquisition Corp (company) — Former company name
- August 20, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
FAQ
What is the nature of the material definitive agreement entered into by Nukkleus Inc. on August 20, 2025?
The filing states that Nukkleus Inc. entered into a material definitive agreement on August 20, 2025, but the specific details of this agreement are not provided in the excerpt.
What other items are included in this 8-K filing besides the material definitive agreement?
Besides the entry into a material definitive agreement, the filing also includes 'Other Events' and 'Financial Statements and Exhibits'.
When is Nukkleus Inc.'s fiscal year end?
Nukkleus Inc.'s fiscal year ends on September 30.
What was Nukkleus Inc.'s former company name?
Nukkleus Inc.'s former company name was Brilliant Acquisition Corp.
In which state is Nukkleus Inc. incorporated?
Nukkleus Inc. is incorporated in Delaware.
Filing Stats: 707 words · 3 min read · ~2 pages · Grade level 12.1 · Accepted 2025-08-25 16:05:51
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value per share NUKK The Nasdaq
- $92.00 — sable for one Share of Common Stock for $92.00 per share NUKKW The Nasdaq Stock Ma
- $100,000 — tions. Nukkleus shall pay Blade Ranger $100,000 for the exclusive U.S. rights, with the
Filing Documents
- ea0254445-8k_nukkleus.htm (8-K) — 33KB
- ea025444501ex10-1_nukkleus.htm (EX-10.1) — 59KB
- 0001213900-25-080347.txt ( ) — 315KB
- nukk-20250820.xsd (EX-101.SCH) — 4KB
- nukk-20250820_def.xml (EX-101.DEF) — 27KB
- nukk-20250820_lab.xml (EX-101.LAB) — 37KB
- nukk-20250820_pre.xml (EX-101.PRE) — 25KB
- ea0254445-8k_nukkleus_htm.xml (XML) — 6KB
01 Entry into a Material Definitive
Item 1.01 Entry into a Material Definitive Agreement On August 20, 2025, Nukkleus Inc. ("Nukkleus" or the "Company") entered into an Exclusive Distribution Agreement (the "Agreement") with Blade Ranger Ltd. ("Blade Ranger"), an Israeli public company specializing in development of drones payloads. Blade Ranger develops and commercializes drone technologies for the solar energy market. In addition, it has developed a payload that is used by defense and homeland security forces. Pursuant to the Agreement, Blade Ranger granted Nukkleus exclusive distribution rights for defense and homeland security sector in the United States for its proprietary product - a unique drone payload that can be used by military forces and homeland security organizations. Nukkleus shall pay Blade Ranger $100,000 for the exclusive U.S. rights, with the first payment is to be made by the end of November 2025, and equal payments are due at the end of the next three consecutive quarters. The Company committed to purchase 5 units in Year 1, 10 units in Year 2, and 15 units in Year 3. Upon meeting these targets, the Agreement extends for an additional five years with a 20 unit annual commitment. If Nukkleus achieves 125% of revenue targets in any year, it will receive an 8% credit on annual purchases. As part of this strategic shift, Nukkleus will incorporate a new subsidiary in Delaware, Nukkleus Defense Technologies, Inc. , to focus on the commercialization of third-party defense-related products, technologies and solutions (including the Blade Ranger products) and to explore the development and commercialization of proprietary solutions targeting defense and aerospace markets. The above description of the Agreement is qualified in its entirety by reference to the Agreement, a copy of which is attached hereto as Exhibit 10.1.
01 Other Events
Item 8.01 Other Events
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits (d) Exhibits Exhibit No. Description 10.1+ Exclusive Distribution Agreement between Nukkleus Inc. and Blade Ranger Ltd., dated August 20, 2025. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) + Portions of this exhibit have been redacted pursuant to Item 601(b)(10)(iv) of Regulation S-K. 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. NUKKLEUS INC. Date: August 25, 2025 By: /s/ Menachem Shalom Name: Menachem Shalom Title: Chief Executive Officer 2